Jennifer L. Barreto-Estrada
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Morphine | 4 | 2024 | 68 | 2.440 |
Why?
|
| Deep Brain Stimulation | 3 | 2024 | 17 | 1.920 |
Why?
|
| Anabolic Agents | 5 | 2017 | 19 | 1.910 |
Why?
|
| Extinction, Psychological | 4 | 2024 | 103 | 1.530 |
Why?
|
| Methyltestosterone | 4 | 2013 | 9 | 1.200 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2024 | 81 | 0.860 |
Why?
|
| Nandrolone | 2 | 2015 | 6 | 0.760 |
Why?
|
| Conditioning, Classical | 2 | 2019 | 67 | 0.710 |
Why?
|
| Hippocampus | 1 | 2024 | 591 | 0.690 |
Why?
|
| Neuronal Plasticity | 2 | 2019 | 126 | 0.680 |
Why?
|
| Conditioning, Operant | 2 | 2017 | 90 | 0.570 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 245 | 0.510 |
Why?
|
| Hypothalamus | 1 | 2017 | 121 | 0.510 |
Why?
|
| Androgens | 1 | 2017 | 107 | 0.510 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2015 | 45 | 0.440 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2024 | 1737 | 0.440 |
Why?
|
| Avoidance Learning | 1 | 2013 | 68 | 0.390 |
Why?
|
| Doping in Sports | 1 | 2011 | 1 | 0.370 |
Why?
|
| Rats | 5 | 2024 | 3701 | 0.360 |
Why?
|
| Animals | 13 | 2024 | 16695 | 0.350 |
Why?
|
| Athletes | 1 | 2011 | 61 | 0.340 |
Why?
|
| Nucleus Accumbens | 3 | 2019 | 99 | 0.330 |
Why?
|
| Testosterone Propionate | 1 | 2008 | 3 | 0.300 |
Why?
|
| Choice Behavior | 1 | 2008 | 91 | 0.280 |
Why?
|
| Sex Characteristics | 2 | 2013 | 253 | 0.280 |
Why?
|
| Copulation | 1 | 2007 | 5 | 0.270 |
Why?
|
| Mating Preference, Animal | 1 | 2007 | 6 | 0.270 |
Why?
|
| Male | 10 | 2024 | 22779 | 0.260 |
Why?
|
| Aggression | 1 | 2007 | 101 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1112 | 0.250 |
Why?
|
| Motor Activity | 2 | 2008 | 438 | 0.240 |
Why?
|
| Ganglia, Sympathetic | 2 | 2003 | 3 | 0.240 |
Why?
|
| Neurons | 3 | 2017 | 1246 | 0.220 |
Why?
|
| Narcotics | 1 | 2024 | 30 | 0.220 |
Why?
|
| Chromaffin Cells | 2 | 2003 | 4 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 1804 | 0.210 |
Why?
|
| Adrenal Medulla | 1 | 2003 | 15 | 0.210 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 28 | 0.210 |
Why?
|
| Mice | 5 | 2017 | 6490 | 0.200 |
Why?
|
| Social Behavior | 1 | 2004 | 160 | 0.200 |
Why?
|
| Sympathetic Nervous System | 2 | 1999 | 64 | 0.160 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 40 | 0.150 |
Why?
|
| Enkephalins | 2 | 1999 | 29 | 0.140 |
Why?
|
| Adrenal Glands | 2 | 1999 | 17 | 0.140 |
Why?
|
| Galanin | 1 | 1997 | 5 | 0.130 |
Why?
|
| Cell Lineage | 1 | 1997 | 104 | 0.120 |
Why?
|
| Synapses | 1 | 2017 | 184 | 0.120 |
Why?
|
| Electric Stimulation | 1 | 2016 | 198 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 82 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 125 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 160 | 0.110 |
Why?
|
| Reward | 1 | 2015 | 106 | 0.110 |
Why?
|
| Cell Line | 1 | 2017 | 1416 | 0.100 |
Why?
|
| Vagina | 1 | 2013 | 89 | 0.100 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 156 | 0.090 |
Why?
|
| Chick Embryo | 3 | 2003 | 77 | 0.090 |
Why?
|
| Substance Abuse Detection | 1 | 2011 | 31 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2017 | 990 | 0.090 |
Why?
|
| Androstane-3,17-diol | 1 | 2010 | 5 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 17 | 0.090 |
Why?
|
| Dihydrotestosterone | 1 | 2010 | 28 | 0.090 |
Why?
|
| Radioimmunoassay | 2 | 2003 | 70 | 0.080 |
Why?
|
| Fear | 1 | 2013 | 271 | 0.080 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 64 | 0.080 |
Why?
|
| Female | 5 | 2013 | 24018 | 0.080 |
Why?
|
| Testosterone | 1 | 2010 | 211 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 764 | 0.080 |
Why?
|
| Darkness | 1 | 2008 | 28 | 0.070 |
Why?
|
| Nerve Growth Factors | 2 | 1999 | 34 | 0.070 |
Why?
|
| Light | 1 | 2008 | 182 | 0.070 |
Why?
|
| Escape Reaction | 1 | 2007 | 15 | 0.070 |
Why?
|
| Puerto Rico | 1 | 2011 | 1376 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1597 | 0.060 |
Why?
|
| Neuropeptide Y | 2 | 2003 | 26 | 0.060 |
Why?
|
| Anxiety | 1 | 2013 | 847 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 574 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1139 | 0.060 |
Why?
|
| Cyclophilins | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 46 | 0.050 |
Why?
|
| Neurites | 1 | 2003 | 40 | 0.050 |
Why?
|
| Cell Count | 1 | 2003 | 140 | 0.050 |
Why?
|
| Ovum | 1 | 2003 | 59 | 0.050 |
Why?
|
| Stem Cells | 1 | 2003 | 151 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 649 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1617 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1265 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1848 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 1999 | 633 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 55 | 0.030 |
Why?
|
| Adult | 1 | 2011 | 13458 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 184 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 928 | 0.030 |
Why?
|
| Phenotype | 1 | 1997 | 774 | 0.030 |
Why?
|
| Lordosis | 1 | 2010 | 4 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2010 | 29 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2010 | 65 | 0.020 |
Why?
|
| Humans | 1 | 2011 | 42163 | 0.020 |
Why?
|
| Motivation | 1 | 2010 | 492 | 0.020 |
Why?
|
| Neurotrophin 3 | 1 | 1999 | 5 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1999 | 5 | 0.010 |
Why?
|
| Somatostatin | 1 | 1999 | 20 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1999 | 44 | 0.010 |
Why?
|
| Catecholamines | 1 | 1999 | 45 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 314 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1999 | 214 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 382 | 0.010 |
Why?
|